Collecting (Bellini) Duct Carcinoma: A Case Report of a Rare Tumor and Review of the Literature

Crossmark: check for updates

Authors

  • Luis Rico Hospital Aleman de Buenos Aires, Av. Pueyrredon 1640, C1118 AAT, Ciudad de Buenos Aires, Argentina
  • Hernando R. Pita Hospital Aleman de Buenos Aires, Av. Pueyrredon 1640, C1118 AAT, Ciudad de Buenos Aires, Argentina
  • Gonzalo Vitagliano Hospital Aleman de Buenos Aires, Av. Pueyrredon 1640, C1118 AAT, Ciudad de Buenos Aires, Argentina
  • Leandro Blas Hospital Aleman de Buenos Aires, Av. Pueyrredon 1640, C1118 AAT, Ciudad de Buenos Aires, Argentina
  • Carlos Ameri Hospital Aleman de Buenos Aires, Av. Pueyrredon 1640, C1118 AAT, Ciudad de Buenos Aires, Argentina

DOI:

https://doi.org/10.17140/UAOJ-4-125

Keywords:

Bellini disease, Collecting ducts carcinoma, Renal carcinoma, sarcomatoid carcinoma

Abstract

Renal cell carcinoma of the collecting ducts is one of the least frequent variants of renal carcinomas, with highly aggressive behavior, having the worst prognosis and the lowest specific cancer survival rate of all renal carcinomas, as 70% of patient deaths are secondary to the disease. We present a clinical case of a male patient with a diagnosis of paraneoplastic syndrome secondary to renal neoplasia. After a renal biopsy returned a diagnosis of sarcomatoid carcinoma, the patient elected surgical excision, and final pathology was consistent with renal carcinoma of the collecting ducts. As was common in the largest published series, this patient developed local and distant relapse in the early post-operative period, despite adjuvant systemic treatment. This variant of renal carcinoma has an ominous short-term prognosis, with high rates of distant disease present at the time of diagnosis. The unfavorable biological behavior manifests despite the use of multi-modality, adjuvant treatment.

References

Karakiewicz PI, Trinh Q, Rioux-Leclerq N, et al. Collecting duct renal cell carcinoma: A matched analysis of 41 cases. Eur Urol. 2007; 52 (4): 1140-1146. doi: 10.1016/j.eururo.2007.01.070

Milowsky MI, Rosmarin A, Tickoo SK, Papanicolaou N, Nanus DM. Active chemotherapy for collecting duct car- cinoma of the kidney: A case report and review of the literature. Cancer. 2002; 94: 111-116. doi: 10.1002/cncr.10204

Chao D, Zisman A, Pantuck AJ, et al. Collecting duct renal cell carcinoma: Clinical study of a rare tumor. J Urol. 2002; 167: 71-74. doi: 10.1016/S0022-5347(05)65385-2

Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T. Collecting duct (Bellini duct) renal cell carci- noma: A nationwide survey in Japan. J Urol. 2006; 176: 40-43. doi: 10.1016/ S0022-5347(06)00502-7

Sui W, Matulay JT, Robins D, et al. Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database. Urologic Oncology. 2017; 35(9): 540. e13-540.e18. doi: 10.1016/j.urolonc.2017.04.010 09

Srigley JR, Delahunt B, Eble JN, et al. The international society of urological pathology (ISUP) vancouver classi cation of renal neoplasia. Am J Surg Pathol. 2013; 37: 1469-1489. doi: 10.1097 Submit your article to this journal | https://openventio.org/submit-manuscript/ 13 Rico L et al PAS.0b013e318299f2d1

Vázquez-Lavista LG, Uribe-Uribe N, Gabilondo-Navarro F. Collecting duct renal cell carcinoma: Two different clinical stages, two different clinical outcomes. Urol Int. 2008; 81: 116-118. doi: 10.1159/000137652

Ciszewski S, Jakimów A, Smolska-Ciszewska B. Collecting (Bellini) duct carcinoma: A clinical study of a rare tumour and review of the literature. Can Urol Assoc J. 2015; 9(9-10): E589-E593. doi: 10.5489/cuaj.2932

Mancilla-Jimenez, R, Stanley, RJ Blath RAM. Papillary renal cell carcinoma. A clinical, radiologic and pathologic study of 34 cases. Cancer. 1976; 38: 2469-2480. doi: 1 0 . 1 0 0 2 / 1 0 9 7 - 0 1 4 2 ( 1 9 7 6 1 2 ) 3 8 : 6 % 3 C 2 4 6 9 : : A I D -CNCR2820380636%3E3.0.CO;2-R

Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol. 2009; 22: S2-S23. doi: 10.1038/ modpathol.2009.70

Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Path. 1997; 183: 131-133. doi: 10.1002/(SICI)1096-9896(199710)183:2%3C131::AID-PATH931%3E3.0.CO;2-G

Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Nagashima Y. Collecting duct carcinoma of the kidney: An inmunohistochemical evaluation of the use of antibodies for differencial diagnosis. Hum Pathol. 2008; 39: 1350-1359. doi: 10.1016/j.humpath.2007.11.020

Igarashi T, Murakami S, Isaka S, Okano T, Shimazaki J, Matsuzaki O. Serum immunosuppressive acid protein as a tumor marker for renal cell carcinoma. Eur Urol. 1991; 19: 332-335. doi: 10.1159/000473654

Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: Differentiation with CT. Radiology. 2007; 244: 494-504.

Oudard S, Banu E, Vieillefond A, et al. Prospective multi-center phase II study of gemcitabine plus platinum salt for metastasic collecting tube carcinomas: Results of a GTUG study. J Urol. 2007; 177: 1698-1702. doi: 10.1016/j.juro.2007.01.063

Motzer RJ, Bacik J, Mariani T, et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol. 2002; 20: 2376-2381. doi: 10.1200/ JCO.2002.11.123

Downloads

Published

2020-05-04

How to Cite

Luis Rico, Hernando R. Pita, Gonzalo Vitagliano, Leandro Blas, & Carlos Ameri. (2020). Collecting (Bellini) Duct Carcinoma: A Case Report of a Rare Tumor and Review of the Literature. Urology and Andrology , 4(1), 10–13. https://doi.org/10.17140/UAOJ-4-125